Articles related to Oncology, Medical

To help ready physicians with sound, scientific knowledge—untarnished by political views—essential to combating COVID-19, the Annals of Internal Medicine and the American College of Physicians hosted the COVID-19 Vaccine Forum on 10/16/20 to offer current, evidence-based information related to the science, approval processes, and development of clinical recommendations for vaccines.

In the past decade, several promising immunotherapies have been developed, changing the treatment landscape for children with relapsed acute lymphoblastic leukemia (ALL). These advances in treatment offer real promise for less toxic and more effective therapy for children. In this article from Blood, the authors present several cases highlighting contemporary treatment decision-making.

In this Celebrity Diagnosis opinion piece from MedPage Today, the author discusses the legendary guitarist’s original throat cancer diagnosis, its possible causes – including Eddie’s own theory — and how it spread to other parts of his head and neck. The article also examines the risks, symptoms, and treatment options of head and neck cancers.

Medscape’s National Physician Burnout and Suicide Report 2020, which surveyed more than 15,000 physicians (prior to the COVID-19 pandemic), found 42% of those interviewed admitted to feeling burned out. Burnout has many causes, but also many solutions. Here are three tips to help you cope on an individualized level.

In this article/podcast from KevinMD.com, the physician authors describe their distress upon hearing and reading the recent disparaging comments about osteopathic medicine, which attacked Navy Commander Dr. Sean Conley, DO, the Physician of the President: “When someone challenges the validity of a legitimate medical degree, the entire house of medicine is under attack.”

The US Food and Drug Administration (FDA) approval – the first for mesothelioma in 16 years and the second FDA-approved systemic therapy for mesothelioma – was based on a randomized, open-label trial, of 605 patients. The endpoint was to determine if the nivolumab-ipilimumab combo improved overall survival compared to chemotherapy.